PACE GARY W

Average Profitability
45.09%
Insider Buys Quantity
17
Insider Buys Sum
$3.45M
Insider Sells Quantity
19
Insider Sells Sum
$15.28M

Insider Activity of PACE GARY W

According to the SEC Form 4 filings, PACE GARY W, being in a position of

  1. director at Cardiff Oncology, Inc.,
    оver the last 12 months, has bought 361615 shares for $940,199, and sold 0 shares,
    over all time since 2020-05-11, has bought 1036426 shares for $2.2M, and sold 0 shares.

The largest purchase of all time was on 2024-12-11 and amounted to 361615 shares of Cardiff Oncology, Inc. for $940,199.

The largest sale of all time was on 2024-03-08 and amounted to 90000 shares of Pacira BioSciences, Inc. for $2.75M.

Biography of PACE GARY W

No biography is available at this moment.

2024-12-11PurchaseCardiff Oncology, Inc.
CRDF
director
361,615
0.5003%
$2.60$940,199+9.46%
2024-03-08SalePacira BioSciences, Inc.
PCRX
director
90,000
0.1889%
$30.60$2.75M-35.16%
2024-03-07SalePacira BioSciences, Inc.
PCRX
director
28,257
0.0613%
$30.81$870,598-32.94%
2024-03-06SalePacira BioSciences, Inc.
PCRX
director
1,066
0.0023%
$29.67$31,628-31.06%
2023-12-19PurchaseCardiff Oncology, Inc.
CRDF
director
30,000
0.0671%
$1.37$41,100+89.78%
2023-05-11SalePacira BioSciences, Inc.
PCRX
director
5,015
0.0109%
$41.78$209,527-25.58%
2022-09-15PurchaseCardiff Oncology, Inc.
CRDF
director
150,000
0.3544%
$1.71$256,500-4.49%
2022-03-01SalePacira BioSciences, Inc.
PCRX
director
1,359
0.003%
$67.75$92,072-19.08%
2022-02-28SalePacira BioSciences, Inc.
PCRX
director
28,641
0.064%
$66.83$1.91M-17.53%
2021-09-21PurchaseCardiff Oncology, Inc.
CRDF
director
30,000
0.0764%
$6.75$202,500-58.36%
2021-03-23PurchaseCardiff Oncology, Inc.
CRDF
director
10,000
0.0273%
$10.23$102,300-37.74%
2021-03-18PurchaseCardiff Oncology, Inc.
CRDF
director
3,000
0.0083%
$10.55$31,660-38.95%
2021-03-04PurchaseCardiff Oncology, Inc.
CRDF
director
1,500
0.0041%
$9.27$13,898-29.09%
2020-09-16PurchaseCardiff Oncology, Inc.
CRDF
director
2,550
0.0107%
$5.70$14,527+72.12%
2020-05-11PurchaseCardiff Oncology, Inc.
CRDF
director
447,761
3.0897%
$1.34$600,000+646.27%
2018-11-19PurchasePacira BioSciences, Inc.
PCRX
director
9,000
0.0219%
$46.18$415,620-12.65%
2018-11-07PurchasePacira BioSciences, Inc.
PCRX
director
8,000
0.0195%
$51.29$410,320-21.28%
2015-03-13PurchasePacira BioSciences, Inc.
PCRX
director
1,000
0.0028%
$93.83$93,830-30.59%
2013-09-09SaleResMed Inc.
RMD
director
12,000
0.0083%
$50.05$600,612-0.55%
2012-08-07SaleResMed Inc.
RMD
director
48,000
0.0339%
$36.00$1.73M+23.56%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.